NCT02084875View on ClinicalTrials.gov

A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 11, 2014

Primary Completion Date

May 25, 2014

Study Completion Date

May 25, 2014

Conditions
Healthy
Interventions
DRUG

tofacitinib modified-release (MR) formulation

A single dose of tofacitinib modified release 11 mg tablet after receiving the standard FDA high fat/high calorie meal.

DRUG

tofacitinib modified-release (MR) formulation

tofacitinib modified release (MR) 11 mg tablet after a 10 hour overnight fast.

Trial Locations (1)

91206

Glendale Adventist Medical Center, Glendale

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02084875 - A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers | Biotech Hunter | Biotech Hunter